Analystreport

Kindred Biosciences Inc (NASDAQ: KIN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Kindred Biosciences, Inc.  (KIN) 
Last kindred biosciences, inc. earnings: 3/16 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: kindredbio.com/investor-relations